These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11333707)

  • 21. How some patients in new-drug trials can get cut off.
    Anand G
    Wall St J (East Ed); 2003 Dec; ():A1, A11. PubMed ID: 14971381
    [No Abstract]   [Full Text] [Related]  

  • 22. On the cusp of change: new therapeutic modalities for HCV.
    Rodríguez-Torres M
    Ann Hepatol; 2010; 9 Suppl():123-31. PubMed ID: 20714009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Structured introduction of new drug therapies: valuable initiative--transparency required].
    Lundkvist J; Henriksson F
    Lakartidningen; 2009 Jan 7-13; 106(1-2):51. PubMed ID: 19235324
    [No Abstract]   [Full Text] [Related]  

  • 24. A new era in drug regulation?
    Dresser R
    Hastings Cent Rep; 2005; 35(3):10-1. PubMed ID: 16092391
    [No Abstract]   [Full Text] [Related]  

  • 25. [New drugs in Spain -- when are they to be considered cost-effective alternatives and profitable investments for the National Health System? ].
    Soto Alvarez J
    Farm Hosp; 2004; 28(4):299-304. PubMed ID: 15369442
    [No Abstract]   [Full Text] [Related]  

  • 26. New anti-HIV drugs and treatment strategies buoy AIDS researchers.
    Stephenson J
    JAMA; 1996 Feb; 275(8):579-80. PubMed ID: 8594227
    [No Abstract]   [Full Text] [Related]  

  • 27. Assessment of new drugs in a tertiary hospital using a standardized tool.
    González-Bueno J; Chamorro-de-Vega E; Alfaro-Lara ER; Galván-Banqueri M; Santos-Ramos B
    Farm Hosp; 2013; 37(5):388-93. PubMed ID: 24128101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Market watch: Upcoming market catalysts in Q3 2016.
    Ranj T
    Nat Rev Drug Discov; 2016 Jul; 15(7):449. PubMed ID: 27282354
    [No Abstract]   [Full Text] [Related]  

  • 29. [Innovation or pseudo-innovation: that is the question].
    Unger T
    Med Klin (Munich); 2006 Mar; 101(3):257-62. PubMed ID: 16648986
    [No Abstract]   [Full Text] [Related]  

  • 30. The pathologist as physician executive. Administrative medicine comes of age.
    Korpman RA
    Arch Pathol Lab Med; 1988 Jun; 112(6):579. PubMed ID: 3377657
    [No Abstract]   [Full Text] [Related]  

  • 31. [Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].
    Bron D; Dewind R; Cantinieaux B; Woff E; Roelandts M; Moerman C; Lemort M; Heimann P; De Wilde V; Meuleman N; Maerevoet M
    Rev Med Brux; 2015 Sep; 36(4):237-47. PubMed ID: 26591307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluating the effectiveness of drugs. "The full potential of a therapy is often only clear after a number of years" (interview by Helmut Laschet)].
    Pfundner H
    MMW Fortschr Med; 2010 Dec; 152(51-52):10. PubMed ID: 21294362
    [No Abstract]   [Full Text] [Related]  

  • 33. A cure at any cost?
    Greco D
    New Sci; 2000 Jul; 167(2245):42-3. PubMed ID: 11885626
    [No Abstract]   [Full Text] [Related]  

  • 34. Japan works to shorten "drug lag," boost trials of new drugs.
    Sinha G
    J Natl Cancer Inst; 2010 Feb; 102(3):148-51. PubMed ID: 20107160
    [No Abstract]   [Full Text] [Related]  

  • 35. A decision analytic approach to a futility analysis of a phase II pharmaceutical study.
    Pallay A
    J Biopharm Stat; 2001 Nov; 11(4):209-25. PubMed ID: 12018776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insomnia market.
    Gershell L
    Nat Rev Drug Discov; 2006 Jan; 5(1):15-6. PubMed ID: 16485342
    [No Abstract]   [Full Text] [Related]  

  • 37. Ethical responsibilities of physicians in the allocation of health care resources.
    Grunberg F; Williams JR
    Ann R Coll Physicians Surg Can; 1988 Jul; 21(5):311-5. PubMed ID: 11650790
    [No Abstract]   [Full Text] [Related]  

  • 38. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. British Biotech fails to redeem itself.
    Michael A
    Nat Biotechnol; 1998 Jul; 16(7):609. PubMed ID: 9661181
    [No Abstract]   [Full Text] [Related]  

  • 40. [Assessment of novel antidiabetic drugs in Germany. Do innovations still have a chance?].
    Gallwitz B
    MMW Fortschr Med; 2014 Jul; 156(13):57-60. PubMed ID: 25318228
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.